Product References
Exploring novel biomarkers in dilated cardiomyopathy‑induced heart failure by integrated analysis and in vitro experiments.
Experimental and therapeutic medicine
Zhou L,Peng F,Li J,Gong H
Sat Jul 01 00:00:00 EDT 2023
Soluble epoxide hydrolase and TRPC3 channels jointly contribute to homocysteine-induced cardiac hypertrophy: Interrelation and regulation by C/EBPβ.
Biochimica et biophysica acta. Molecular basis of disease
Zhou Y,Wang XC,Wei JH,Xue HM,Sun WT,He GW,Yang Q
Sat Apr 01 00:00:00 EDT 2023
GLUT4 mediates the protective function of gastrodin against pressure overload-induced cardiac hypertrophy.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Zhang M,Tan Y,Song Y,Zhu M,Zhang B,Chen C,Liu Y,Shi L,Cui J,Shan W,Jia Z,Feng L,Cao G,Yi W,Sun Y
Mon May 01 00:00:00 EDT 2023
Chronic β-adrenergic stress contributes to cardiomyopathy in rodents with collagen-induced arthritis.
Acta pharmacologica Sinica
Zhu ZD,Zhang M,Wang Z,Jiang CR,Huang CJ,Cheng HJ,Guan QY,Su TT,Wang MM,Gao Y,Wu HF,Wei W,Han YS,Wang QT
Sun Oct 01 00:00:00 EDT 2023
G9a inhibition promotes the formation of pacemaker-like cells by reducing the enrichment of H3K9me2 in the HCN4 promoter region.
Molecular medicine reports
Xu P,Jin K,Zhou J,Gu J,Gu X,Dong L,Sun X
Wed Feb 01 00:00:00 EST 2023
Metformin Collaborates with PINK1/Mfn2 Overexpression to Prevent Cardiac Injury by Improving Mitochondrial Function.
Biology
Ma Z,Liu Z,Li X,Zhang H,Han D,Xiong W,Zhou H,Yang X,Zeng Q,Ren H,Xu D
Tue Apr 11 00:00:00 EDT 2023
HypERlnc attenuates angiotensin II-induced cardiomyocyte hypertrophy via promoting SIRT1 SUMOylation-mediated activation of PGC-1α/PPARα pathway in AC16 cells.
Cell biology international
Yue L,Sheng S,Yuan M,Lu J,Li T,Shi Y,Dong Z
Thu Jun 01 00:00:00 EDT 2023
Trim65 attenuates isoproterenol-induced cardiac hypertrophy by promoting autophagy and ameliorating mitochondrial dysfunction via the Jak1/Stat1 signaling pathway.
European journal of pharmacology
Liu H,Zhou Z,Deng H,Tian Z,Wu Z,Liu X,Ren Z,Jiang Z
Thu Jun 15 00:00:00 EDT 2023
Trim65 attenuates isoproterenol-induced cardiac hypertrophy by promoting autophagy and ameliorating mitochondrial dysfunction via the Jak1/Stat1 signaling pathway.
European journal of pharmacology
Liu H,Zhou Z,Deng H,Tian Z,Wu Z,Liu X,Ren Z,Jiang Z
Thu Jun 15 00:00:00 EDT 2023
Trim65 attenuates isoproterenol-induced cardiac hypertrophy by promoting autophagy and ameliorating mitochondrial dysfunction via the Jak1/Stat1 signaling pathway.
European journal of pharmacology
Liu H,Zhou Z,Deng H,Tian Z,Wu Z,Liu X,Ren Z,Jiang Z
Thu Jun 15 00:00:00 EDT 2023
Trim65 attenuates isoproterenol-induced cardiac hypertrophy by promoting autophagy and ameliorating mitochondrial dysfunction via the Jak1/Stat1 signaling pathway.
European journal of pharmacology
Liu H,Zhou Z,Deng H,Tian Z,Wu Z,Liu X,Ren Z,Jiang Z
Thu Jun 15 00:00:00 EDT 2023
Transient Receptor Potential Vanilloid Type 1 Protects Against Pressure Overload-Induced Cardiac Hypertrophy by Promoting Mitochondria-Associated Endoplasmic Reticulum Membranes.
Journal of cardiovascular pharmacology
Wang Y,Li X,Xu X,Qu X,Yang Y
Thu Sep 01 00:00:00 EDT 2022
Cullin-associated and neddylation-dissociated 1 protein (CAND1) governs cardiac hypertrophy and heart failure partially through regulating calcineurin degradation.
Pharmacological research
Li X,Zhang Y,Zhao Y,Zhou Y,Han Q,Yang Y,Zhang L,Shi L,Jin X,Zhang R,Gao H,Xue G,Li D,Zhang ZR,Lu Y,Yang B,Pan Z
Mon Aug 01 00:00:00 EDT 2022
SUMOylation of SIRT1 activating PGC-1α/PPARα pathway mediates the protective effect of LncRNA-MHRT in cardiac hypertrophy.
European journal of pharmacology
Liu MY,Yue LJ,Luo YC,Lu J,Wu GD,Sheng SQ,Shi YQ,Dong ZX
Mon Sep 05 00:00:00 EDT 2022
Overexpression of cytosolic long noncoding RNA cytb protects against pressure-overload-induced heart failure via sponging microRNA-103-3p.
Molecular therapy. Nucleic acids
Zhang X,Yuan S,Liu J,Tang Y,Wang Y,Zhan J,Fan J,Nie X,Zhao Y,Wen Z,Li H,Chen C,Wang DW
Tue Mar 08 00:00:00 EST 2022
regulates pathological cardiac hypertrophy via a β-catenin-dependent mechanism.
American journal of physiology. Heart and circulatory physiology
Lin L,Xu W,Li Y,Zhu P,Yuan W,Liu M,Shi Y,Chen Y,Liang J,Chen J,Yang B,Cai W,Wen Y,Zhu X,Peng X,Zhou Z,Mo X,Wan Y,Yuan H,Li F,Ye X,Jiang Z,Wang Y,Zhuang J,Fan X,Wu X
Thu Apr 01 00:00:00 EDT 2021
CBL aggravates Ang II-induced cardiac hypertrophy via the VHL/HIF-1α pathway.
Experimental cell research
Yang Y,Zou P,He L,Shao J,Tang Y,Li J
Sun Aug 15 00:00:00 EDT 2021
Gastrodin Exerts Cardioprotective Action via Inhibition of Insulin-Like Growth Factor Type 2/Insulin-Like Growth Factor Type 2 Receptor Expression in Cardiac Hypertrophy.
ACS omega
Lu J,Ma X,Gao WC,Zhang X,Fu Y,Liu Q,Tian L,Qin XD,Yang W,Zheng HY,Zheng CB
Tue Jul 06 00:00:00 EDT 2021
Examination of the Effect of a 50-Hz Electromagnetic Field at 500 μT on Parameters Related With the Cardiovascular System in Rats.
Frontiers in public health
Zhang Y,Li L,Liu X,Ding L,Wu X,Wang J,He M,Hou H,Ruan G,Lai J,Chen C
Fri May 14 00:00:00 EDT 2021
Ranolazine prevents pressure overload-induced cardiac hypertrophy and heart failure by restoring aberrant Na+ and Ca2+ handling.
Journal of cellular physiology
Nie J,Duan Q,He M,Li X,Wang B,Zhou C,Wu L,Wen Z,Chen C,Wang DW,Alsina KM,Wehrens XHT,Wang DW,Ni L
Mon Jul 01 00:00:00 EDT 2019
Ranolazine prevents pressure overload-induced cardiac hypertrophy and heart failure by restoring aberrant Na+ and Ca2+ handling.
Journal of cellular physiology
Nie J,Duan Q,He M,Li X,Wang B,Zhou C,Wu L,Wen Z,Chen C,Wang DW,Alsina KM,Wehrens XHT,Wang DW,Ni L
Mon Jul 01 00:00:00 EDT 2019